ABT Abbott Laboratories

Price (delayed)

$111.30

Market cap

$197.26B

P/E Ratio

58.58

Dividend/share

$1.53

EPS

$1.9

Enterprise value

$211.35B

Sector: Healthcare
Industry: Medical Devices

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights

Abbott Laboratories's net income has increased by 9% QoQ and by 2.7% YoY
ABT's quick ratio is up by 9% since the previous quarter and by 9% year-on-year
ABT's P/E is 23% above its last 4 quarters average of 47.6 but 20% below its 5-year quarterly average of 73.5
ABT's gross margin is down by 3.2% year-on-year

Key stats

What are the main financial stats of ABT
Market
Shares outstanding
1.77B
Market cap
$197.26B
Enterprise value
$211.35B
Valuations
Price to earnings (P/E)
58.58
Price to book (P/B)
6.24
Price to sales (P/S)
6.13
EV/EBIT
47.88
EV/EBITDA
27.7
EV/Sales
6.56
Earnings
Revenue
$32.22B
EBIT
$4.41B
EBITDA
$7.63B
Free cash flow
$4.59B
Per share
EPS
$1.9
Free cash flow per share
$2.58
Book value per share
$17.84
Revenue per share
$18.16
TBVPS
$17.19
Balance sheet
Total assets
$69.04B
Total liabilities
$37.45B
Debt
$18.56B
Equity
$31.6B
Working capital
$7.13B
Liquidity
Debt to equity
0.59
Current ratio
1.7
Quick ratio
1.01
Net debt/EBITDA
1.85
Margins
EBITDA margin
23.7%
Gross margin
56.7%
Net margin
10.5%
Operating margin
13.4%
Efficiency
Return on assets
5%
Return on equity
10.9%
Return on invested capital
13.5%
Return on capital employed
7.5%
Return on sales
13.7%
Dividend
Dividend yield
1.37%
DPS
$1.53
Payout ratio
80.5%

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
1.15%
1 week
-0.28%
1 month
3.58%
1 year
27.37%
YTD
1.65%
QTD
1.65%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$32.22B
Gross profit
$18.28B
Operating income
$4.31B
Net income
$3.38B
Gross margin
56.7%
Net margin
10.5%
Abbott Laboratories's net income has increased by 9% QoQ and by 2.7% YoY
The operating income has grown by 7% from the previous quarter
Abbott Laboratories's net margin has increased by 6% QoQ
Abbott Laboratories's operating margin has increased by 4.7% from the previous quarter but it has decreased by 2.2% YoY

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
P/E
58.58
P/B
6.24
P/S
6.13
EV/EBIT
47.88
EV/EBITDA
27.7
EV/Sales
6.56
ABT's P/E is 23% above its last 4 quarters average of 47.6 but 20% below its 5-year quarterly average of 73.5
The EPS has grown by 9% from the previous quarter and by 2.2% YoY
ABT's price to book (P/B) is 64% higher than its 5-year quarterly average of 3.8 and 20% higher than its last 4 quarters average of 5.2
ABT's equity is up by 2.6% since the previous quarter
ABT's P/S is 53% above its 5-year quarterly average of 4.0 and 20% above its last 4 quarters average of 5.1
The revenue has grown by 2.8% YoY and by 2.5% from the previous quarter

Efficiency

How efficient is Abbott Laboratories business performance
ABT's ROE is up by 9% from the previous quarter and by 3.8% YoY
Abbott Laboratories's return on assets has increased by 9% QoQ and by 4.2% YoY
The ROIC has grown by 5% from the previous quarter
The ROS has grown by 4.6% from the previous quarter but it has contracted by 4.2% YoY

Dividends

What is ABT's dividend history
DPS
$1.53
Dividend yield
1.37%
Payout ratio
80.5%
Recent dividends

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 84% more than the total liabilities
The current ratio has increased by 10% YoY and by 8% QoQ
ABT's quick ratio is up by 9% since the previous quarter and by 9% year-on-year
Abbott Laboratories's debt is 41% lower than its equity
Abbott Laboratories's debt has decreased by 6% QoQ and by 2.8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.